Login / Signup

Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases.

Nazlıhan Boyacı DündarDavid SarphieKenan YüceÜmmügülsüm GaygısızO Tolga KaskatıMelda TürkoğluŞahender Gülbin Aygencel BıkmazLale KarabıyıkKayhan ÇağlarGulendam BozdayiRubina MianPaul MossMustafa Necmi İlhan
Published in: Intensive care medicine experimental (2023)
, shows that ROS production generally declined back to normal levels for patients who survived, but remained elevated for those patients who did not survive.
Keyphrases
  • cell death
  • dna damage
  • coronavirus disease
  • reactive oxygen species
  • sars cov
  • early onset